Cysteamine Bitartrate is Used for treating nephropathic cystinosis. It was first introduced by Mylan Pharmaceuticals Inc in its drug Cystagon on Aug 15, 1994. Another drug containing Cysteamine Bitartrate is Procysbi. 2 different companies have introduced drugs containing Cysteamine Bitartrate.

Cysteamine Bitartrate Patents

Given below is the list of patents protecting Cysteamine Bitartrate, along with the drug name that holds that patent and the company name owning that drug.

Download patent list as spreadsheet

Get the complete list right in your inbox!

Drug Used in	Drug Patent Number	Drug Patent Title	Drug Patent Expiry	Drug Owner
Procysbi	US10143665 (Pediatric)	Methods for storing cysteamine formulations and related methods of treatment	Feb 16, 2037	Horizon
Procysbi	US10328037 (Pediatric)	Methods for storing cysteamine formulations and related methods of treatment	Feb 16, 2037	Horizon
Procysbi	US10548859 (Pediatric)	Methods for storing Cysteamine formulations and related methods of treatment	Feb 16, 2037	Horizon
Procysbi	US10905662 (Pediatric)	Methods for storing cysteamine formulations and related methods of treatment	Feb 16, 2037	Horizon
Procysbi	US10143665	Methods for storing cysteamine formulations and related methods of treatment	Aug 16, 2036	Horizon
Procysbi	US10328037	Methods for storing cysteamine formulations and related methods of treatment	Aug 16, 2036	Horizon
Procysbi	US10548859	Methods for storing Cysteamine formulations and related methods of treatment	Aug 16, 2036	Horizon
Procysbi	US10905662	Methods for storing cysteamine formulations and related methods of treatment	Aug 16, 2036	Horizon
Procysbi	US9173851 (Pediatric)	Delayed release cysteamine bead formulation, and methods of making and using same	Dec 17, 2034	Horizon
Procysbi	US9233077 (Pediatric)	Delayed release cysteamine bead formulation, and methods of making and using same	Dec 17, 2034	Horizon
Procysbi	US9173851	Delayed release cysteamine bead formulation, and methods of making and using same	Jun 17, 2034	Horizon
Procysbi	US9233077	Delayed release cysteamine bead formulation, and methods of making and using same	Jun 17, 2034	Horizon
Procysbi	US8026284 (Pediatric)	Enterically coated cystamine, cysteamine and derivatives thereof	Mar 22, 2028	Horizon
Procysbi	US8026284	Enterically coated cystamine, cysteamine and derivatives thereof	Sep 22, 2027	Horizon
Procysbi	US9192590 (Pediatric)	Enterically coated cysteamine, cystamine and derivatives thereof	Jul 26, 2027	Horizon
Procysbi	US9198882 (Pediatric)	Enterically coated cysteamine, cystamine and derivatives thereof	Jul 26, 2027	Horizon
Procysbi	US9925156 (Pediatric)	Enterically coated cysteamine, cystamine and derivatives thereof	Jul 26, 2027	Horizon
Procysbi	US9925157 (Pediatric)	Enterically coated cysteamine, cystamine and derivatives thereof	Jul 26, 2027	Horizon
Procysbi	US9925158 (Pediatric)	Enterically coated cysteamine, cystamine and derivatives thereof	Jul 26, 2027	Horizon
Procysbi	US8129433	Enterically coated cysteamine, cystamine and derivatives thereof	Jan 26, 2027	Horizon
Procysbi	US9192590	Enterically coated cysteamine, cystamine and derivatives thereof	Jan 26, 2027	Horizon
Procysbi	US9198882	Enterically coated cysteamine, cystamine and derivatives thereof	Jan 26, 2027	Horizon
Procysbi	US9925156	Enterically coated cysteamine, cystamine and derivatives thereof	Jan 26, 2027	Horizon
Procysbi	US9925156	Enterically coated cysteamine, cystamine and derivatives thereof	Jan 26, 2027	Horizon
Procysbi	US9925157	Enterically coated cysteamine, cystamine and derivatives thereof	Jan 26, 2027	Horizon
Procysbi	US9925157	Enterically coated cysteamine, cystamine and derivatives thereof	Jan 26, 2027	Horizon
Procysbi	US9925158	Enterically coated cysteamine, cystamine and derivatives thereof	Jan 26, 2027	Horizon
Procysbi	US9925158	Enterically coated cysteamine, cystamine and derivatives thereof	Jan 26, 2027	Horizon

Add above patents to watchlist

Cysteamine Bitartrate's Family Patents

Full family tree